Dacomitinib Anhydrous vs Imatinib

## Dacomitinib Anhydrous vs Imatinib: Overview

This comparison examines the pharmacological differences between **Dacomitinib Anhydrous** and **Imatinib**.

## Mechanism of Action

**Imatinib**: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

## Pharmacokinetics

**Half-life**: Dacomitinib Anhydrous — N/A; Imatinib — 18 hours.

## Chemical Properties

**Molecular Formula**: Dacomitinib Anhydrous — N/A; Imatinib — C29H31N7O.

**Molecular Weight**: Dacomitinib Anhydrous — N/A; Imatinib — 493.6030 g/mol.

**Type**: Dacomitinib Anhydrous — Small molecule; Imatinib — Small molecule.